Sort   by:  
 Page size 
UnknownClinical report: one year of treatment of Proteus syndrome with miransertib (ARQ 092).
Not available
S-EPMC6996520 | biostudies-literature
UnknownRandomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
Not available
S-EPMC5836800 | biostudies-literature
UnknownDerazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
Not available
S-EPMC6342954 | biostudies-literature
Sort   by:  
 Page size